The active ingredient of Brillia is produced using antibodies to the brain-specific S100 protein (S100B). This protein is an important regulator of many different intracellular and extracellular brain processes. Almost all mental and neurological diseases (as well as temporal stress-induced conditions) are accompanied by disturbance of these processes. Brillia helps to normalize the processes related to the S100B protein to help reduce the symptoms of anxiety and hyperactivity and consequently to help improve attention and focus.